Usefulness of positron emission tomography for differentiating gliomas according to the 2016 World Health Organization classification of tumors of the central nervous system

被引:24
|
作者
Takei, Hiroaki [1 ,2 ,4 ]
Shinoda, Jun [1 ,2 ,3 ]
Ikuta, Soko [5 ]
Maruyama, Takashi [5 ]
Muragaki, Yoshihiro [5 ]
Kawasaki, Tomohiro [1 ,2 ,4 ]
Ikegame, Yuka [1 ,2 ,3 ]
Okada, Makoto [1 ,2 ]
Ito, Takeshi [1 ,2 ]
Asano, Yoshitaka [1 ,2 ,3 ]
Yokoyama, Kazutoshi [1 ,2 ]
Nakayama, Noriyuki [4 ]
Yano, Hirohito [4 ]
Iwama, Toru [4 ]
机构
[1] Kizawa Mem Hosp, Dept Neurosurg, Minokamo, Gifu, Japan
[2] Kizawa Mem Hosp, Chubu Med Ctr Prolonged Traumat Brain Dysfunct, Minokamo, Gifu, Japan
[3] Gifu Univ, Grad Sch Med, Dept Clin Brain Sci, Gifu, Japan
[4] Gifu Univ, Grad Sch Med, Dept Neurosurg, Gifu, Japan
[5] Tokyo Womens Med Univ, Dept Neurosurg, Tokyo, Japan
基金
日本学术振兴会;
关键词
C-11-methionine; C-11-choline; F-18-fluorodeoxyglucose; positron emission tomography; glioma; isocitrate dehydrogenase mutation; oncology; C-11-METHIONINE PET; C-11; METHIONINE; IDH2; MUTATIONS; BRAIN-TUMORS; F-18-FDG PET; SURVIVAL; C-11-CHOLINE; DIAGNOSIS; NECROSIS; CHOLINE;
D O I
10.3171/2019.5.JNS19780
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
OBJECTIVE: Positron emission tomography (PET) is important in the noninvasive diagnostic imaging of gliomas. There are many PET studies on glioma diagnosis based on the 2007 WHO classification; however, there are no studies on glioma diagnosis using the new classification (the 2016 WHO classification). Here, the authors investigated the relationship between uptake of 11C-methionine (MET), 11C-choline (CHO), and 18F-fluorodeoxyglucose (FDG) on PET imaging and isocitrate dehydrogenase (IDH) status (wild-type [IDH-wt] or mutant [IDH-mut]) in astrocytic and oligodendroglial tumors according to the 2016 WHO classification. METHODS: In total, 105 patients with newly diagnosed cerebral gliomas (6 diffuse astrocytomas [DAs] with IDH-wt, 6 DAs with IDH-mut, 7 anaplastic astrocytomas [AAs] with IDH-wt, 24 AAs with IDH-mut, 26 glioblastomas [GBMs] with IDH-wt, 5 GBMs with IDH-mut, 19 oligodendrogliomas [ODs], and 12 anaplastic oligodendrogliomas [AOs]) were included. All OD and AO patients had both IDH-mut and 1p/19q codeletion. The maximum standardized uptake value (SUV) of the tumor/mean SUV of normal cortex (T/N) ratios for MET, CHO, and FDG were calculated, and the mean T/N ratios of DA, AA, and GBM with IDH-wt and IDH-mut were compared. The diagnostic accuracy for distinguishing gliomas with IDH-wt from those with IDH-mut was assessed using receiver operating characteristic (ROC) curve analysis of the mean T/N ratios for the 3 PET tracers. RESULTS: There were significant differences in the mean T/N ratios for all 3 PET tracers between the IDH-wt and IDH-mut groups of all histological classifications (p < 0.001). Among the 27 gliomas with mean T/N ratios higher than the cutoff values for all 3 PET tracers, 23 (85.2%) were classified into the IDH-wt group using ROC analysis. In DA, there were no significant differences in the T/N ratios for MET, CHO, and FDG between the IDH-wt and IDH-mut groups. In AA, the mean T/N ratios of all 3 PET tracers in the IDH-wt group were significantly higher than those in the IDH-mut group (p < 0.01). In GBM, the mean T/N ratio in the IDH-wt group was significantly higher than that in the IDH-mut group for both MET (p = 0.034) and CHO (p = 0.01). However, there was no significant difference in the ratio for FDG. CONCLUSIONS: PET imaging using MET, CHO, and FDG was suggested to be informative for preoperatively differentiating gliomas according to the 2016 WHO classification, particularly for differentiating IDH-wt and IDH-mut tumors.
引用
收藏
页码:1010 / 1019
页数:10
相关论文
共 50 条
  • [41] Reclassification of Glioblastoma Multiforme According to the 2021 World Health Organization Classification of Central Nervous System Tumors: A Single Institution Report and Practical Significance
    Stoyanov, George S.
    Lyutfi, Emran
    Georgieva, Reneta
    Georgiev, Radoslav
    Dzhenkov, Deyan L.
    Petkova, Lilyana
    Ivanov, Borislav D.
    Kaprelyan, Ara
    Ghenev, Peter
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (02)
  • [42] Analysis of the clinical impact of the diagnostic reclassification of brain gliomas according to the World Health Organization classification (2016)
    Mateo-Sierra, Olga
    Alcala-Torres, Juan
    Serret-De Troya, Carlos
    Valera-Mele, Marc
    Sola-Vendrell, Emma
    REVISTA DE NEUROLOGIA, 2019, 69 (10) : 402 - 408
  • [43] The 2016 World Health Organization classification of tumours of the Central Nervous System: what the paediatric neuroradiologist needs to know
    Chhabda, Sahil
    Carney, Olivia
    D'Arco, Felice
    Jacques, Thomas S.
    Mankad, Kshitij
    QUANTITATIVE IMAGING IN MEDICINE AND SURGERY, 2016, 6 (05) : 486 - 489
  • [44] Tumors of the central nervous system. World Health Organization Classification 2021. Towards a paradigm shift
    del Rio, Ramiro J.
    Cicutti, Santiago E.
    Ramos, Javier D. Gonzalez
    ARCHIVOS ARGENTINOS DE PEDIATRIA, 2024,
  • [45] The New World Health Organization Classification of Central Nervous System Tumors: What Can the Neuroradiologist Really Say?
    Osborn, A. G.
    Salzman, K. L.
    Thurnher, M. M.
    Rees, J. H.
    Castillo, M.
    AMERICAN JOURNAL OF NEURORADIOLOGY, 2012, 33 (05) : 795 - 802
  • [46] Tumors of the central nervous system. Classification of the World Health Organization 2021. Towards a paradigm shift
    del Rio, Ramiro J.
    Cicutti, Santiago E.
    Ramos, Javier D. Gonzalez
    ARCHIVOS ARGENTINOS DE PEDIATRIA, 2024, 122 (04):
  • [47] Brain Invasion in Meningiomas: The Rising Importance of a Uniform Neuropathologic Assessment After the Release of the 2016 World Health Organization Classification of Central Nervous System Tumors
    Brokinkel, Benjamin
    Stummer, Walter
    WORLD NEUROSURGERY, 2016, 95 : 614 - 615
  • [48] Diagnostic value of 18F-fiuorodeoxyglucose positron emission tomography for pancreatic neuroendocrine tumors with reference to the World Health Organization classification
    Masui, Toshihiko
    Doi, Ryuichiro
    Ito, Tatsuo
    Kami, Kazuhiro
    Ogawa, Kohei
    Harada, Daisuke
    Uemoto, Shinji
    ONCOLOGY LETTERS, 2010, 1 (01) : 155 - 159
  • [49] Classification of Central Nervous System Tumors - WHO 2016 Update
    Polivka, J.
    Repik, T.
    Holubec, L.
    Polivka, J., Jr.
    CESKA A SLOVENSKA NEUROLOGIE A NEUROCHIRURGIE, 2017, 80 (03) : 353 - 356
  • [50] Positron emission tomography in central nervous system drug discovery and development
    Cooper, M
    Metz, J
    NEUROIMAGING CLINICS OF NORTH AMERICA, 2003, 13 (04) : 851 - +